Orange prescription bottle tipped on its side with white pills spilling out beside its cap

Judge Again Rejects Huntington Opioid Case Against Distributors

A federal judge in West Virginia has again entered judgment for AmerisourceBergen Drug Corp., Cardinal Health and McKesson, concluding that the City of Huntington and Cabell County failed to prove the drug distributors were responsible for a public nuisance in their community.

Senior U.S. District Judge David A. Faber of the Southern District of West Virginia filed amended findings of fact and conclusions of law on November 18, 2026, about a year after a federal appeals court threw out his first decision for the distributors and sent the case back to him. AmerisourceBergen Drug Corp. is a unit of Cencora.

A case nearly a decade old

Huntington and Cabell County sued in 2017. Their cases became part of the national opioid litigation (MDL 2804, centralized in the Northern District of Ohio) and were later sent back to West Virginia for trial as “Track Two” bellwether cases. The local governments brought a single claim, public nuisance, alleging that the distributors shipped so many prescription opioids into the area that they created an epidemic. Instead of money damages, they asked the court to order a 15-year abatement plan to address the crisis, which their expert priced at about $2.5 billion.

Judge Faber heard the case without a jury from May 3 to July 12, 2021. On July 4, 2022, he ruled for the distributors, predicting that West Virginia would not extend public nuisance law to the distribution of opioids and finding that the plaintiffs had not proved a nuisance in any event.

On appeal, the U.S. Court of Appeals for the Fourth Circuit asked the West Virginia Supreme Court of Appeals to decide whether the state’s public nuisance law covers opioid distribution. That court declined to answer in 2025, saying the question turned on facts. On October 28, 2025, the Fourth Circuit answered it instead. It held that an unreasonable interference with a right common to the general public resulting from opioid distribution may qualify as a public nuisance under West Virginia law when the evidence shows the distribution unreasonably hurts or inconveniences an indefinite number of people. It also ruled that Judge Faber had read the distributors’ duties under the federal Controlled Substances Act too narrowly, and sent the case back. The appeals court told him to look again at the distributors’ suspicious order monitoring, their pattern of raising order limits, and their review of orders from pharmacies that supplied what the appeals court called “outlier” doctors, who it said accounted for about 40 percent of the opioids prescribed in Cabell County.

What the judge found this time

After hearing arguments on May 28, 2026, Judge Faber again ruled that the plaintiffs had not proved their case. Applying the standard the Fourth Circuit set, he found that the distributors substantially complied with their duties under the Controlled Substances Act to monitor and report suspicious orders, and that the plaintiffs did not prove the companies failed to maintain effective controls against diversion. He also found that the plaintiffs had not shown the distributors’ conduct unreasonably interfered with a public right or caused the harm alleged.

Much of the ruling addresses what drove the volume of opioids shipped into the area. Judge Faber found that the volume was driven by prescriptions written by doctors, and he wrote that “the distribution of medicine to support the legitimate medical needs of patients as determined by doctors exercising their medical judgment in good faith cannot be deemed an unreasonable interference with a right common to the general public.”

The city and county argued that a significant share of the supply traced to illegal prescribing by what they called “outlier” doctors. The judge wrote that the plaintiffs “never really showed” that, but he added that those doctors “should not get a free pass as, without their actions, there would never have been the oversupply that plaintiffs assert caused the opioid epidemic in Cabell/Huntington.”

The judge also found that the diversion shown at trial happened after pharmacies dispensed the pills, or outside pharmacies entirely: pills taken from medicine cabinets, patients “doctor shopping,” forged prescriptions, sales by drug dealers and trafficking into the area. Even if the distributors’ conduct had played a part, he concluded, three independent acts broke the chain of causation: doctors’ prescribing decisions, pharmacists’ dispensing decisions and the choices of people who abused prescription and illegal opioids.

On one of the Fourth Circuit’s concerns, how few suspicious orders the companies reported to the Drug Enforcement Administration, the judge pointed to testimony from Joseph Rannazzisi, who ran the DEA’s Office of Diversion Control from 2005 to 2015, that the number of suspicious order reports reaching the agency should be small.

What the distributors would owe if found liable

Although he found no liability, the judge also reviewed the local governments’ abatement plan, so the case would not need a second remand if the Fourth Circuit disagrees with him. He struck some programs from the plan, bringing its cost to about $1.76 billion, and reduced that by 25 percent for harm tied to illegal, non-prescription opioids. He then allocated one-fourth of the remaining costs to the distributors, saying the doctors, manufacturers and pharmacies involved would also bear responsibility for any nuisance. That would limit the distributors’ share of any abatement remedy to $329,596,804, with any lump-sum award reduced to present value. The plan as the city and county proposed it carried a 15-year cost of about $2.54 billion.

He declined to cut the amount further based on the distributors’ market share, though he found that, if such a cut were ever needed, the three companies accounted for 84 percent of the opioids distributed in Huntington and Cabell County during the relevant period.

What happens next

Paul Farrell, a lawyer for the city and county, told WV MetroNews that they will appeal to the Fourth Circuit again. “We’re not at the end yet,” he said. Mountain State Spotlight also reported that he plans to appeal.

Earlier this month, a judge in King County, Washington, ordered Albertsons to pay $900 million over the opioid crisis after a bench trial in a case brought by the state attorney general. For more on major rulings, verdicts and settlements, see LegalScoops’ mass tort news.